Accurate testing is essential to distinguish between respiratory pathogens

Molecular testing for respiratory pathogens helps laboratories maximize sensitivity for common viruses, including SARS-CoV-2, influenza, and RSV. Adoption of multiplex testing assays has grown over the last few years, most notably as a response to the SARS-CoV-2 pandemic. Although we have entered an endemic phase, we expect SARS-CoV-2 and its variants to remain with us indefinitely. SARS-CoV-2 now joins the list of respiratory pathogens that pathologists will see in the lab, and influenza and COVID-19 share symptoms, making differential detection even more challenging.


Multiplex testing assays allow laboratories to test for multiple infectious disease targets in a single reaction. This helps providers rule out multiple respiratory infections with one patient sample.

Molecular diagnostic solutions for respiratory testing

Molecular techniques including PCR-based tests are designed to enable early virus detection, even in asymptomatic cases, and help deliver reliable answers.

Applied Biosystems real-time PCR respiratory research products

Our molecular detection solutions enable the comprehensive analysis of various respiratory pathogens, encompassing viruses, bacteria, and fungi without the inherent challenges associated with immunoassay-based and culture-based techniques.

Respiratory pathogen detection resources

Gain valuable insights, tips, and best practices to enhance your understanding and proficiency in utilizing our state-of-the-art PCR technology. Our educational resources are designed to cater to both seasoned researchers and those who are new to the field, to help you achieve accurate and reliable results.